Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Physiological studies of the deep-water coral Madrepora oculata incubated at different temperatures and hydrostatic pressures.

The Journal of experimental biology·2026

Same author

Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control study.

European journal of medical research·2025

Same author

Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusion.

Cardiovascular diabetology·2023

Same author

[Soft tissue necrotizing infection].

Revue medicale de Liege·2022

Same author

Scallop Theorem and Swimming at the Mesoscale.

Physical review letters·2021

Same author

Surface swimmers, harnessing the interface to self-propel.

The European physical journal. E, Soft matter·2018

Search research articles

Related Experiment Video

Updated: May 28, 2026

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

[Physical therapy for parkinson's disease].

¹Service de Kinésithérapie neurologique, Hôpital Erasme, Bruxelles. marcelle.hubert@ulb.ac.be

Revue Medicale De Bruxelles

|November 1, 2011

Summary

Physiotherapy can significantly improve autonomy and independence for Parkinson's disease (PD) patients by addressing motor symptoms and providing education. Evidence-based guidelines support tailored physical therapy interventions to enhance quality of life.

Area of Science:

Neurology
Physical Therapy
Gerontology

Context:

Parkinson's disease (PD) is a progressive neurologic disorder impacting millions globally, with patient numbers expected to rise.
Despite medical and surgical treatments, PD patients experience increasing functional impairments and reduced participation in daily life.
Current physical therapy approaches for PD lack uniformity, necessitating evidence-based guidelines.

Purpose:

To determine the efficacy of physiotherapy in optimally managing Parkinson's disease symptoms.
To outline how and on what scientific basis physiotherapists can enhance patient autonomy and independent living.
To provide clinicians with an integrated overview of evidence-based physical therapy management for Parkinson's disease.

Summary:

More Related Videos

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Experiment Videos

Last Updated: May 28, 2026

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

A systematic literature search and integration of clinical research findings informed the development of an Evidence-Based Physical Therapy Guideline.

Key areas of physical therapy intervention include transfers, posture, balance, reaching/grasping, gait, and physical conditioning, supported by randomized clinical trials.

Patient and family education on the disease process and exercise therapy benefits are crucial, alongside consideration of complementary therapies like Tai Chi, yoga, and dancing.

Impact:

Implementation of evidence-based physical therapy can improve functional independence and quality of life for individuals with Parkinson's disease.
Optimized physiotherapy management may help delay institutionalization and reduce the burden on healthcare systems.
Standardized, evidence-based physical therapy practices will enhance the role of physiotherapists in comprehensive Parkinson's disease care.